The point company has not been onto PR has made it difficult for continuous SP rise. Last quarterly should have news of AU enteric site open, FDA application, new partner overseas and winter flu testing sales, due in 2 weeks time. Both FY22 report and FY23 outlook should be bright and take SP upwards from here.
- Forums
- ASX - By Stock
- Ann: Genetic Signatures completes $35m placement
GSS
genetic signatures limited
Add to My Watchlist
1.28%
!
39.5¢

The point company has not been onto PR has made it difficult for...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
39.5¢ |
Change
0.005(1.28%) |
Mkt cap ! $89.71M |
Open | High | Low | Value | Volume |
39.5¢ | 39.5¢ | 39.5¢ | $304 | 769 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 37.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.0¢ | 95869 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 0.375 |
4 | 36154 | 0.370 |
1 | 10000 | 0.365 |
2 | 7013 | 0.360 |
1 | 40000 | 0.355 |
Price($) | Vol. | No. |
---|---|---|
0.400 | 95869 | 1 |
0.420 | 40000 | 2 |
0.455 | 5000 | 1 |
0.480 | 500 | 1 |
0.490 | 13000 | 1 |
Last trade - 11.30am 18/07/2025 (20 minute delay) ? |
Featured News
GSS (ASX) Chart |